**Question:** Ischemia/reperfusion (I/R) injury is considered to be a MAJOR mechanism for organ transplant failure. Allopurinol is used in organ preservation as:

A. Reducing urate levels
B. Inhibiting neutrophil activation
C. Protecting against I/R injury
D. Increasing oxygen delivery to the organ

**Correct Answer:** C. Protecting against I/R injury

**Core Concept:**
Ischemia/reperfusion (I/R) injury refers to the damage that occurs when blood flow to a tissue or organ is restored after a period of ischemia (lack of blood flow). This process can lead to cellular damage, inflammation, and oxidative stress, contributing to the failure of organ transplantation. Allopurinol is a medication primarily used to reduce urate levels in patients with hyperuricemia, a condition characterized by high blood urate levels.

**Why the Correct Answer is Right:**
Allopurinol is used in organ preservation to protect against I/R injury. As an xanthine oxidoreductase inhibitor, allopurinol prevents the formation of reactive oxygen species (ROS) during I/R injury, thereby reducing cellular damage, inflammation, and oxidative stress. This helps to maintain the organ's function and prevents transplant failure.

**Why Each Wrong Option is Incorrect:**

A. Reducing urate levels (Option A) is not the primary function of allopurinol. While it does lower urate levels, this option does not address the primary mechanism of allopurinol in organ preservation.

B. Inhibiting neutrophil activation (Option B) is not the primary mechanism of allopurinol in organ preservation. The primary role is to prevent ROS formation, not specifically neutrophil activation.

D. Increasing oxygen delivery to the organ (Option D) is irrelevant to the primary function of allopurinol in organ preservation. Allopurinol's effect is on ROS formation, not oxygen delivery.

**Clinical Pearl:**
Understanding the role of allopurinol in organ preservation is crucial for transplant surgeons and physicians, as it helps to maintain organ function, reduce transplant rejection rates, and improve patient outcomes. By focusing on preventing ROS formation, allopurinol contributes to reducing I/R injury and preserving the organ's function, ultimately reducing the risk of transplant failure.